CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Biomarin Pharmaceutical's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleTotal Oppositions
Mar 13, 2024Use Of C-Type Natriuretic Peptide Variants To Treat Skeletal Dysplasia3
May 11, 2022Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of Measuring5
Jan 26, 2022Treatment Of Phenylketonuria With Bh43
Dec 1, 2021Variants Of C-Type Natriuretic Peptide2
Dec 16, 2020Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of Measuring5

Top competitors of Biomarin Pharmaceutical

List of top competitors of Biomarin Pharmaceutical based on patent oppositions.